Howard Her‐Juing Wu

Howard Her‐Juing Wu

Auto-generated profile, based on publicly available information

Howard Her‐Juing Wu

Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis Indiana USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2011 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
HWHoward Her‐Juing Wu
Howard Her‐Juing Wu
CRCrystal Rose
Crystal Rose
TETarik M. Elsheikh
Tarik M. Elsheikh

25 October 2013 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
HWHoward H. Wu
Howard H. Wu
AIAshley Inman
Ashley Inman
HCHarvey M. Cramer
Harvey M. Cramer

13 December 2018 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ASAmikar Sehdev
Amikar Sehdev
OGOlumide Gbolahan
Olumide Gbolahan
BHBrad A. Hancock
Brad A. Hancock
MSMelissa Stanley
Melissa Stanley
SSSafi Shahda
Safi Shahda
BOBert H. O’nEil
Bert H. O’nEil
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with lack of predictive biomarkers. We conducted a study to assess DNA damage repair (DDR) gene mutations as a predictive biomarker in PDAC patients treated with FOLFIRINOX. Experimental Design: Indiana University Simon Cancer Center pancreatic cancer database was used to identify patients with metastatic PDAC, treated with FOLFIRINOX and had tissue available for DNA sequencing. Baseline demographic, clinical, and pathologic information was gathered. DNA isolation and targeted sequencing was performed using the Ion AmpliSeq protocol. Overall survival (OS) analysis was conducted using Kaplan–Meier, logistic regression and Cox proportional hazard methods. Multivariate models were adjusted for age, gender, margin status, CA 19-9, adjuvant chemotherapy, tumor and nodal stage. Results: Overall, 36 patients were sequenced. DDR gene mutations were found in 12 patients. Mutations were seen in BRCA1 (N = 7), BRCA2 (N = 5), PALB2 (N = 3), MSH2 (N = 1), and FANCF (N = 1) of all the DDR genes sequenced. Median age was 65.5 years, 58% were male, 97.2% were Caucasian and 51.4% had any family history of cancer. The median OS was near significantly superior in those with DDR gene mutations present vs. absent [14 vs. 5 months; HR, 0.58; 95% confidence interval (CI), 0.29–1.14; log-rank P = 0.08]. Multivariate logistic (OR, 1.47; 95% CI, 1.04–2.06; P = 0.04) and Cox regression (HR, 0.37; 95% CI, 0.15–0.94; P = 0.04) showed presence of DDR gene mutations was associated with improved OS. Conclusions: In a single institution, retrospective study, we found that the presence of DDR gene mutations are associated with improved OS in PDAC patients treated with FOLFIRINOX.

23 March 2017 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
CYChi‐Shun Yang
Chi‐Shun Yang
ECEuna Choi
Euna Choi
MIMuhammad T. Idrees
Muhammad T. Idrees
SCShaoxiong Chen
Shaoxiong Chen
HWHoward H. Wu
Howard H. Wu
BACKGROUND: In recent years, there have been increasing indications for percutaneous renal biopsy. Fine‐needle aspiration (FNA), with or without core needle biopsy (CB), has been used increasingly in the management of renal tumors at the study institution.METHODS: A computerized search of laboratory records was conducted to retrieve FNA cases of renal masses as well as the correlating CB and/or nephrectomy specimens. The cases spanned a period of 10 years (2006‐2015). The diagnoses were classified into 5 categories: malignant, suspicious for malignancy, neoplastic, atypical, and negative/nondiagnostic. Based on the results of the nephrectomy specimens, the diagnostic rate, sensitivity, and diagnostic accuracy were calculated among 3 groups of specimens: FNA only, CB only, and combined FNA and CB.RESULTS: A total of 247 cases of FNA with 123 correlating CB and 101 follow‐up nephrectomy specimens were identified. The diagnostic rate, sensitivity, and diagnostic accuracy were 72%, 78%, and 96%, respectively, for FNA; 87%, 92%, and 94%, respectively, for CB; and 92%, 92%, and 94%, respectively, for the combined FNA and CB group. Renal cell carcinoma and its variants were the most common histologic diagnoses (112 of 174 cases; 64%). Significant diagnostic discrepancy was noted in one case: a malignant melanoma that was misdiagnosed as renal cell carcinoma in both the preoperative FNA specimen and in the CB specimen.CONCLUSIONS: In the current study, both FNA and CB demonstrated excellent diagnostic accuracy (96% and 94%, respectively). The combination of FNA and CB was found to significantly improve the diagnostic rate when compared with either FNA alone (92% vs 72%; P<.05) or CB alone (92% vs 87%). Cancer Cytopathol 2017;125:407–15. © 2017 American Cancer Society.

16 July 2012 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
JFJill Ferguson
Jill Ferguson
PCPierce Chamberlain
Pierce Chamberlain
HCHarvey M. Cramer
Harvey M. Cramer
HWHoward H. Wu
Howard H. Wu

11 March 2016 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
KPKristen L. Partyka
Kristen L. Partyka
EHEric C. Huang
Eric C. Huang
HCHarvey M. Cramer
Harvey M. Cramer
SCShaoxiong Chen
Shaoxiong Chen
HWHoward H. Wu
Howard H. Wu
BACKGROUND Although fine-needle aspiration (FNA) has an important role in evaluating thyroid nodules in adults, there is little published information regarding its utility in the pediatric population. METHODS A retrospective analysis of thyroid FNAs for patients who were 18 years old or younger at 2 institutions was conducted. Aspirates were retrospectively categorized with the Bethesda System for Reporting Thyroid Cytopathology. These diagnoses were then correlated with either final histopathology or clinical follow-up. RESULTS A total of 186 thyroid FNA samples from 154 patients (122 females and 32 males), who ranged in age from 9 months to 18 years (median, 16 years; mean, 14 years), were identified. FNA was performed to evaluate 1 to 3 nodules for each patient. Aspirates were classified as follows: nondiagnostic (n = 27), benign (n = 114), atypia of undetermined significance (AUS; n = 21), follicular neoplasm (FN; n = 8), suspicious for malignancy (n = 3), and malignant (n = 13). Sixty-one samples had a histologic correlation, 68 were followed clinically for ≥2 years, and 57 either had no follow-up or were followed for <2 years. For statistical purposes, FNA diagnoses of suspicious and malignant were considered positive, and benign lesions were considered negative. The accuracy was 99%, and the sensitivity and specificity were 94% and 100%, respectively. The risk of malignancy, not including papillary microcarcinoma, was 2% for benign aspirates, 21% for AUS, 57% for FN, and 100% for suspicious or malignant aspirates. CONCLUSIONS This analysis demonstrates that FNA is a sensitive and highly specific modality for evaluating thyroid nodules in pediatric patients. Each diagnostic category can facilitate communication and guide appropriate management. Cancer Cytopathol 2016;124:467–71. © 2016 American Cancer Society.